Every SEC Form 3/4/5 on record for this filer (CIK 1277966) — 2 issuers, 89 transactions. Section-16 filings only: what they filed, not a biography, and titles are as filed on their latest form at each issuer.
| Ticker | Company | Role as filed | On file | Forms | Open-market net |
|---|---|---|---|---|---|
| KLRS | Kalaris Therapeutics, Inc. | Director | 2025-03-18 → 2025-04-11 | 3 | — |
| OPHT | Ophthotech Corp. | President · Director · lapsed | 2015-07-22 → 2017-02-14 | 22 | −$21M |
| Ticker | Date | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| OPHT | 2017-01-05 | Sell | 815 | $4.96 | $4,042 | 15,813 |
| OPHT | 2017-01-05 | Sell | 3,029 | $4.96 | $15,024 | 16,628 |
| OPHT | 2017-01-03 | Sell | 2,999 | $4.90 | $14,695 | 13,407 |
| OPHT | 2016-09-29 | Sell | 2,612 | $54.93 | $143,477 | 21,627 |
| OPHT | 2016-09-29 | Sell | 2,000 | $56.90 | $113,800 | 11,531 |
1 of 2 issuers are covered and open a security page; the rest are on file here only.